Ian M. Mawer
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ian M. Mawer.
Tetrahedron | 1989
Joseph P. Vacca; S. Jane deSolms; Joel R. Huff; David C. Billington; Raymond Baker; Janusz Jozef Kulagowski; Ian M. Mawer
Abstract Total synthesis of the individual enantiomers of myo-inositol 4-phosphate ( 15 ), myo-inositol 1,4-bisphosphate ( 2 ) and myo-inositol 1,4,5-trisphosphate ( 1 ), together with syntheses of racemic myo-inositol 1,3,4-trisphosphate ( 4 ) and myo-inositol 2,4,5-trisphosphate ( 5 ) are reported. The syntheses feature the use of camphanic acid esters for resolution of protected inositols, and the use of tetrabenzylpyrophosphate as an efficient phosphorylating agent for polyhydroxy alcohols.
Neuropharmacology | 1998
Linda J. Bristow; Gina P Cook; Smita Patel; Neil Roy Curtis; Ian M. Mawer; Janusz Jozef Kulagowski
The putative D3 receptor agonist, (+)-PD 128907, is widely used to study the functional relevance of D3 receptors in vivo. Given that non-selective D2/3/4 receptor agonists serve as effective discriminative stimuli in rats we have trained animals to discriminate (+)-PD 128907 (30 microg kg(-1), s.c.) from saline and examined the pharmacological specificity of the response. Consistent with a D3 receptor mediated response, the non-selective D2/3 receptor agonist apomorphine and the D3 preferring agonists 7-OH-DPAT and (-) quinpirole generalised to the cue whilst the D2/3 receptor antagonists haloperidol, raclopride, spiperone and (+)-butaclamol antagonised drug lever responding. In contrast, the D1 selective agonist (+/-)-SKF 81297 and D1/5 selective antagonist, R-(+)-SCH 23390 had no effect. Results also suggest that presynaptic dopamine receptors are involved. Thus the dopamine depleting agent alpha-methyl-p-tyrosine potentiated the effects of a submaximal dose of (+)-PD 128907 whereas amphetamine failed to generalise per se and blocked (+)-PD 128907 lever selection. However, studies using subtype selective antagonists argue against a role for the D3 receptor. Thus the 10-fold selective D2 receptor antagonist L-741,626 blocked the (+)-PD 128907 discriminative stimulus whereas L-745,829 and GR 103,691, antagonists > 40 and > 100-fold selective for D3 receptors, failed to modify the response. These results suggest that presynaptic D2 receptors mediate the discriminative stimulus properties of (+)-PD 128907 and highlight the lack of selectivity of (+)-PD 128907 for D3 receptors in vivo.
Bioorganic & Medicinal Chemistry Letters | 1993
Paul D. Leeson; Raymond Baker; Robert W. Carling; Janusz Jozef Kulagowski; Ian M. Mawer; Mark Peter Ridgill; Michael Rowley; Julian D. Smith; Ian Stansfield; Graeme Irvine Stevenson; Alan C. Foster; John A. Kemp
Abstract 3-Substituted-2-quinoloners ( 6–8 ) have been identified as glycine-site N-methyl-D-aspartate receptor antagonists. It is proposed that the α-phenyl lactam unit in the potent 4-hydroxy-3-phenyl derivatives ( 7d and 8b , L-701,315) may act as a glycine bioisostere in receptor recognition.
Journal of The Chemical Society-perkin Transactions 1 | 1989
David C. Billington; Raymond Baker; Janusz Jozef Kulagowski; Ian M. Mawer; Joseph P. Vacca; S. Jane deSolms; Joel R. Huff
Novel selective alkylations of myo-inositol orthoformate (4) have been used to prepare a series of protected myo-inositol derivatives, (5a–e), (7), (10), (12), and (16). These intermediates have been used in efficient total syntheses of myo-inositol 2-phosphate, (9); myo-inositol 4-phosphate, (6); myo-inositol 1,3-bisphosphate, (18); and myo-inositol 1,3,4,5-tetrakisphosphate (14). This report represents the first total synthesis of the important natural metabolites (14) and (18) and significantly improved methods of preparation of (6) and (9).
Bioorganic & Medicinal Chemistry Letters | 1995
Ian M. Mawer; Janusz Jozef Kulagowski; Paul D. Leeson; Sarah Grimwood; George Marshall
Abstract Tetramic acids ( 9 ) have been designed as novel glycine site N-methyl-D-aspartate receptor antagonists.
Journal of The Chemical Society, Chemical Communications | 1987
David C. Billington; Raymond Baker; Janusz Jozef Kulagowski; Ian M. Mawer
New methodology is described which allows the synthesis of myo-inositol 1-phosphate completely free of contamination by the 2-isomer, and novel resolution procedures have been developed for the preparation of the enantiomers of myo-inositol 1- and 4-phosphates.
Bioorganic & Medicinal Chemistry Letters | 1996
Neil Roy Curtis; Janusz Jozef Kulagowski; Paul D. Leeson; Ian M. Mawer; Mark Peter Ridgill; Michael Rowley; Sarah Grimwood; George Marshall
Abstract A series of analogues of the novel diiodotyrosine derived NMDA glycine-site ligand (R)-4 was prepared in which the aryl substitution, chain length and amino acid groups were varied. The key structural features for binding are the α-amino acid function, having the (R) absolute stereochemistry, the 3,5-diiodo substituted aromatic ring and a lipophilic group attached at the phenolic oxygen of the tyrosine moiety.
Journal of Medicinal Chemistry | 1996
Janusz Jozef Kulagowski; Howard B. Broughton; Neil Roy Curtis; Ian M. Mawer; Mark Peter Ridgill; Baker R; Frances Emms; Stephen B. Freedman; Rosemarie Marwood; Shil Patel; Ragan Ci; Paul D. Leeson
Journal of Medicinal Chemistry | 1993
Robert W. Carling; Paul D. Leeson; Kevin William Moore; Julian D. Smith; Christopher Richard Moyes; Ian M. Mawer; Steven Thomas; Tony Chan; Raymond Baker; Alan C. Foster; Sarah Grimwood; John A. Kemp; George R. Marshall; Mark D. Tricklebank; Kay L. Saywell
Archive | 1993
Janusz Jozef Kulagowski; Paul D. Leeson; Ian M. Mawer